|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01553344 |
|
Date of registration:
|
12/03/2012 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Serum Sclerostin Level & Treatment of Vitamin D Deficiency
OMSOST |
|
Scientific title:
|
Serum Sclerostin Level in Patients With Vitamin D Deficiency |
|
Date of first enrolment:
|
March 2012 |
|
Target sample size:
|
26 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01553344 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Contacts
|
|
Name:
|
MUHARREM CIDEM, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Bagcilar Training & Research Hospital Istanbul, Turkey |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Premenopausal
- Serum 25(OH)D < 10 ng/mL
Exclusion Criteria:
- Anemia
- Tumor-induced osteomalacia (hypophosphatemia)
- Hypothyroidism
- Hepatic / renal disease
- Primary hyperparathyroidism
- Fibromyalgia
- Polymyalgia rheumatica
- Serum 25(OH)D > 10 ng/mL
- Vitamin D and calcium treatment commenced prior to study participation
Age minimum:
20 Years
Age maximum:
50 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Vitamin D Deficiency
|
|
Endocrine System Diseases
|
|
Primary Outcome(s)
|
|
Serum sclerostin level
[Time Frame: 8 weeks]
|
|
Secondary ID(s)
|
|
BEAH FTR -7
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|